聯誠精密(002921.SZ):公司為上海神力公司等客户開發生產的氫能源相關零件產品已實現正常供貨
格隆匯6月28日丨有投資者於投資者互動平台向聯誠精密(002921.SZ)提問,“貴公司入股上海神力投資氫能源,這項投資是否符合公司發展方向?公司和上海神力的產品合作,怎麼樣了,開發了哪些產品?有沒有批量生產?”
公司回覆稱,公司參股投資氫燃料電池領域知名企業上海神力,有助於進一步加深公司對相關行業的理解,併為雙方後續在資本或業務層面進一步可能合作奠定良好的基礎;公司為上海神力公司等客户開發生產的氫能源相關零件產品已實現正常供貨,未來如有對公司經營業績有重大影響的事項,我們將按照有關法律法規的要求及時進行信息披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.